Alexander Mark Schobel - Chief Innovation/Tech Officer at Aquestive Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Innovation/Tech Officer
Issuer Symbol
AQST on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Alexander Mark Schobel since 07 Feb 2025

Holdings reported by Alexander Mark Schobel for Aquestive Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 984,476 $5,906,856 $6.00 15 Mar 2024 Direct
Performance Stock Units 50,000 09 Aug 2023 Direct Common Stock
Non-Qualified Stock Option (right to buy) 41,250 07 Mar 2024 Direct Common Stock

Transactions reported by Alexander Mark Schobel for Aquestive Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.